Cadila Healthcare Limited Formoterol Export Data — India (DGFT 2022–2026)

Name: Cadila Healthcare Limited Formoterol Export Records India — #10 Exporter, 11 Shipments, $145.5K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Formoterol

India Pharmaceutical Trade Intelligence

$57.4M153 Suppliers81 CountriesHS 30049099

ExportsIndia → UNITED STATES67.3%India → SRI LANKA8.3%

#1 Supplier: CIPLA LIMITED #1 Buyer: LIFESTAR PHARMA

Cadila Healthcare Limited — Formoterol Exporter #10 | $299.9K Trade Value | TransData Nexus | TransData Nexus

Cadila Healthcare Limited — Formoterol Exporter Profile

Indian Pharmaceutical Exporter · #10 for Formoterol · $299.9K export value · DGFT Verified

Cadila Healthcare Limited is the #10 Indian exporter of Formoterol with $299.9K in export value and 11 verified shipments. Cadila Healthcare Limited holds a 0.3% market share in Formoterol exports across 2 countries. The company exports 41 pharmaceutical products worth $34.9M across 17 therapeutic categories.

Cadila Healthcare Limited — Formoterol Export Profile: Buyers & Destinations

Cadila Healthcare Limited Formoterol export treemap — buyers and destination countries | TransData Nexus

Where Does Cadila Healthcare Limited Export Formoterol?

Country	Value	Shipments	Share
SRI LANKA	$184.3K	20	70.1%
VIETNAM	$50.0K	1	19.0%
KENYA	$13.1K	1	5.0%
SUDAN	$9.6K	1	3.7%
MAURITIUS

Who Are the Top Buyers of Formoterol from Cadila Healthcare Limited?

Buyer	Country	Value	Orders
SUNSHINE HEALTHCARE LANKA LIMITED	SRI LANKA	$184.3K	20
HAPHARCOJ S CBRANCH	VIETNAM	$50.0K	1
GALAXY PHARMACEUTICAL LIMITED	KENYA	$13.1K	1
M PHARMA CO LTD	SUDAN	$9.6K	1
FTM MAURITIUS LTD	MAURITIUS	$5.8K	2

Cadila Healthcare Limited supplies Formoterol to 5 buyers globally. The largest buyer is SUNSHINE HEALTHCARE LANKA LIMITED (SRI LANKA), followed by HAPHARCOJ S CBRANCH (VIETNAM) and GALAXY PHARMACEUTICAL LIMITED (KENYA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Formoterol Formulations Does Cadila Healthcare Limited Export?

Product Description / Formulation	Value	Shipments
FORMONIDE 400 MDI 1'S- HFAFORMOTEROL FUMARATE & BUDESONIDE INHALATION1 X 1 UNIT	$80.5K	7
FORMONIDE 200 INHALERBUDESONIDE & FORMOTEROL FUMARATE INHALER1X120MDI	$50.0K	1
FORMONIDE 400 MDI 1'S- HFAFORMOTEROL FU	$39.6K	2
FORMONIDE 200 RESPICAPSBUDESONIDE AND FORMOTEROL FUMARATE RESPICAP3X10	$22.2K	6
FORMONIDE 400 MDI 1'S- HFA FORMOTEROL F	$22.1K	1
FORMONIDE 200 MDI 1'S- HFAFORMOTEROL FUMARATE & BUDESONIDE INHALATION1 X 1 UNIT	$13.5K	2
FORMONIDE 400 INHALER BUDESONIDE & FORMOTEROL FUMARATE INHALER 1X120MDI	$13.1K	1
FORMONIDE200HFA INHCFC FREE120MDIBUDESONIDE & FORMOTEROL FUMARATE INHALER1X 120 MD	$9.6K	1
FORMONIDE 200 MDI 1'S- HFAFORMOTEROL FU	$3.2K	1
FORMONIDE 400 RESPICAPS BUDESONIDE AND FORMOTEROL FUMARATE RESPICAP B.No AHZ1013A MANUFACTURING .DT. 08/2023 EXP.DT. 01/2025	$3.2K	1

Cadila Healthcare Limited exports 12 distinct Formoterol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FORMONIDE 400 MDI 1'S- HFAFORMOTEROL FUMARATE & BUDESONIDE I with 7 shipments worth $80.5K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Cadila Healthcare Limited Compare to Nearest Formoterol Exporters?

Exporters ranked immediately above and below #10 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
7	MEDISPRAY LABORATORIES PVT LTD	$200.0K	4	1	$50.0K
9	CADILA HEALTHCARE LTD	$154.5K	14	4	$11.0K
10	CADILA HEALTHCARE LIMITED ★	$145.5K	11	2	$13.2K
11	SAVIOUR INTERNATIONAL	$117.2K	12	2	$9.8K
12	SAVA HEALTHCARE LIMITED	$117.1K	323	3	$363

Cadila Healthcare Limited ranks #10 among 153 Indian Formoterol exporters. Average shipment value of $13.2K compared to the market average of $255.0K. The closest competitors by value are MEDISPRAY LABORATORIES PVT LTD and CADILA HEALTHCARE LTD.

Which Indian Ports Ship Formoterol Exports?

Port	Shipments	% Share
SAHAR AIR	898	18.3%
DELHI AIR	817	16.6%
DELHI AIR CARGO ACC (INDEL4)	758	15.4%
SAHAR AIR CARGO ACC (INBOM4)	660	13.4%
NHAVA SHEVA SEA (INNSA1)	322	6.5%
Delhi Air	256	5.2%
Bombay Air	139	2.8%
Bombay Air Cargo	99	2.0%

Geopolitical & Trade Policy Impact on Cadila Healthcare Limited's Formoterol Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Zydus. The escalating conflict in the Middle East has disrupted key maritime routes, particularly the Red Sea and Suez Canal, leading to longer transit times and increased freight costs. Major carriers have suspended or restricted transits, extending transit times by 10–20 days and raising freight rates by 40–50% on key India–Europe routes. (livemint.com) This situation poses significant challenges for time-sensitive pharmaceutical shipments, especially temperature-sensitive medicines. (economictimes.indiatimes.com)

Conversely, U.S.–China trade tensions have prompted the U.S. to impose tariffs on Chinese pharmaceutical imports, creating an opportunity for Indian exporters to fill the supply gap. However, the U.S. has also introduced tariffs on Indian imports, including a 25% "reciprocal" tariff, followed by an additional 25% penalty tied to India's continued imports of Russian oil, bringing the total duty to 50%. (en.wikipedia.org) While pharmaceuticals are currently exempt, the potential for future tariffs necessitates strategic planning.

In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial. The FMD mandates stringent serialization and traceability requirements to prevent counterfeit medicines from entering the supply chain. Non-compliance can result in restricted market access, making adherence to these regulations imperative for exporters like Zydus.

Cadila Healthcare Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. FDA, WHO, and EU Good Manufacturing Practice (GMP) guidelines set stringent quality benchmarks. Any lapses can lead to import alerts, product recalls, or facility shutdowns. For instance, in 2019, Zydus's Moraiya facility received an Official Action Indicated (OAI) classification from the U.S. FDA, indicating that regulatory and/or administrative actions were recommended. (moneycontrol.com) Such events underscore the importance of robust quality assurance systems.

The evolving regulatory landscape demands continuous investment in compliance infrastructure. The EU's Falsified Medicines Directive and the U.S. Drug Supply Chain Security Act (DSCSA) require advanced serialization and traceability measures. Non-compliance can result in restricted market access, making adherence to these regulations imperative for exporters like Zydus.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Formoterol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Cadila Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 25 individual customs records matching Cadila Healthcare Limited exporting Formoterol, covering 12 formulations to 5 countries via 5 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 81+ countries, 320+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Formoterol

Formoterol

Cadila Healthcare Limited — Formoterol Exporter Profile

Cadila Healthcare Limited — Formoterol Export Profile: Buyers & Destinations

Where Does Cadila Healthcare Limited Export Formoterol?

Who Are the Top Buyers of Formoterol from Cadila Healthcare Limited?

What Is India's Total Formoterol Export Value and How Much Does Cadila Healthcare Limited Contribute?

What Is the Average Shipment Value for Cadila Healthcare Limited's Formoterol Exports?

How Does Cadila Healthcare Limited Compare to Other Indian Formoterol Exporters?

What Formoterol Formulations Does Cadila Healthcare Limited Export?

How Does Cadila Healthcare Limited Compare to Nearest Formoterol Exporters?

Which Indian Ports Ship Formoterol Exports?

What Other Respiratory Products Does Cadila Healthcare Limited Export?

Geopolitical & Trade Policy Impact on Cadila Healthcare Limited's Formoterol Exports

Cadila Healthcare Limited — Regulatory Compliance & Quality Standards

About Cadila Healthcare Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Formoterol Export Data from Cadila Healthcare Limited

Formoterol Stats

Company Overview

Top Products by Cadila Healthcare Limited

Related Analysis

Need Detailed Export Data?

Data Source